Showing results (461-470 of 622) with videos related to

Sort By:
Pageof 63
Cancer|December 20, 2005
Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphomaAlan D Dosik, Morton Coleman, Lale Kostakoglu, et al.
The Science of the Total Environment|January 5, 2021
Role of emission controls in reducing the 2050 climate change penalty for PM2.5 in ChinaSong Liu, Jia Xing, Daniel M Westervelt, et al.
Il Giornale Di Chirurgia|February 28, 1998
[Intravascular surgery in the treatment of peripheral arteriopathies: our experience]E De Antoni, B Salvati, R Capoano, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2006
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesityA Bartolomucci, G La Corte, R Possenti, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 26, 2025
In silico evaluation of the potential of very high energy electrons delivered in both conventional and FLASH regimes for the SBRT treatment of pancreatic cancer: A report of three case studiesA De Gregorio, A Muscato, A Burattini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2014
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study)S Bauer, P Rutkowski, P Hohenberger, et al.
Environmental Science & Technology|October 11, 2022
Investigating Changes in Ozone Formation Chemistry during Summertime Pollution Events over the Northeastern United StatesMadankui Tao, Arlene M Fiore, Xiaomeng Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphomaJohn P Leonard, Morton Coleman, Jamie Ketas, et al.
Chest|July 4, 2021
Optimal Tricuspid Regurgitation Velocity to Screen for Pulmonary Hypertension in Tertiary Referral CentersBryce E Montané, Andrew M Fiore, Emily C Reznicek, et al.
Pageof 63